Prenetics GlobalPRE
PRE
About: Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Employees: 285
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.1% more ownership
Funds ownership: 10.71% [Q4 2024] → 10.81% (+0.1%) [Q1 2025]
0% more funds holding
Funds holding: 9 [Q4 2024] → 9 (+0) [Q1 2025]
31% less capital invested
Capital invested by funds: $6.6M [Q4 2024] → $4.57M (-$2.03M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for PRE.
Financial journalist opinion
Based on 3 articles about PRE published over the past 30 days
Neutral
GlobeNewsWire
2 weeks ago
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder
CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today at a special event at Wimbledon House that IM8, its premium supplements brand co-founded by David Beckham, has partnered with world No. 1 tennis star Aryna Sabalenka as its newest global ambassador and shareholder. The announcement comes just days before the start of Wimbledon on June 30th, where Sabalenka will be competing as one of the tournament favorites.
Neutral
GlobeNewsWire
3 weeks ago
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
- Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation
Neutral
GlobeNewsWire
3 weeks ago
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a leading consumer health sciences company, today announced it has entered into a definitive agreement to divest its ownership in ACT Genomics Holdings Company Limited (“ACT Genomics”) to Delta Electronics, Inc. (TWSE: 2308) (“Delta”). Delta is a global leader in power management and smart green solutions, as well as a provider of healthcare technologies. The transaction regarding Delta's acquisition of up to 100% ACT Genomics' shareholdings is valued at up to US$71.78 million. Prenetics, holding a majority stake in ACT Genomics, will receive a gross proceed of approximately US$46 million in cash post-closing of the transaction and subject to customary release conditions. With a cash balance of US$44 million1, this divestment bolsters Prenetics financial position, increasing its pro-forma cash reserves to approximately US$86 million2 and with $117 million pro-forma short term assets3, while maintaining a debt-free balance sheet.
Neutral
GlobeNewsWire
3 months ago
Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University
Neutral
GlobeNewsWire
4 months ago
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024
Neutral
GlobeNewsWire
4 months ago
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare company, today announced a groundbreaking genomics-based partnership with Humanity Protocol, a decentralized identity verification company. This collaboration leverages Prenetics' advanced genetic testing capabilities to underpin decentralized identity verification.
Neutral
GlobeNewsWire
5 months ago
Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials
– David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence – Tested for 280+ banned substances, trusted by global athletes in WADA, NFL, NBA, MLB, PGA and more – IM8 is available at IM8health.com , shipping to 31 countries and regions CHARLOTTE, N.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Prenetics' IM8, a premium supplements brand co-founded by David Beckham, announces its flagship product, Daily Ultimate Essentials, has been certified to NSF Certified for Sport®, a globally recognized standard for supplement safety, quality, and transparency.
Neutral
GlobeNewsWire
7 months ago
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics' IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the International Space Station (ISS). Launched via SpaceX CRS-31 on November 4th at 9:29 pm EST, the mission aims to study accelerated aging and longevity by leveraging microgravity's unique environment to accelerate aging processes at the cellular level.
Neutral
GlobeNewsWire
7 months ago
Prenetics Announces Participation in December Investor Conferences
CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.
Neutral
GlobeNewsWire
7 months ago
Prenetics Announces Third Quarter 2024 Financial Results
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially
Charts implemented using Lightweight Charts™